Phathom Pharmaceuticals, Inc. Annual Interest Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Phathom Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2018 to 2023.
  • Phathom Pharmaceuticals, Inc. Interest Expense for the quarter ending June 30, 2024 was $17.8M, a 84.8% increase year-over-year.
  • Phathom Pharmaceuticals, Inc. Interest Expense for the twelve months ending June 30, 2024 was $58.1M, a 54% increase year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Interest Expense for 2023 was $42M, a 53.7% increase from 2022.
  • Phathom Pharmaceuticals, Inc. annual Interest Expense for 2022 was $27.3M, a 302% increase from 2021.
  • Phathom Pharmaceuticals, Inc. annual Interest Expense for 2021 was $6.79M, a 48.2% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $42M +$14.7M +53.7% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-06-14
2022 $27.3M +$20.5M +302% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-06-14
2021 $6.79M +$2.21M +48.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $4.58M +$404K +9.67% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $4.18M +$4.16M +32031% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 $13K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.